Strategy.

 

Overview

 

Frontier Pharma targets investment opportunities with enterprise values between $15 million and $100 million however has the flexibility to consider other deal sizes.

We are typically long-term investors without a defined exit horizon.

We seek opportunities where our technical & commercial expertise may be leveraged to create value, through operational improvements, restructuring, internationalisation and business development. Our focus areas can be found below:

Sectors

 

  • Branded Generics

  • Established brands

  • Consumer Health (OTC)

  • Biologics

Capabilities

 

  • Strong local & international compliance track record

  • Advanced capabilities (e.g. sterile, controlled release)

  • Competitive production costs

  • Mid to high capacity utilisation with room for expansion

Portfolio

 

  • Differentiated and niche portfolio

  • Valued and trusted brands, beacons of quality

  • Internationally diversified or well suited for export markets

Financials

 

  • Track record for growth or in a high growth market

  • Profitable or prospect of near-term profitability

  • Well-invested operations

Culture

 

  • Culture of excellence, team-work, trust & innovation

  • Strong reputation for quality, compliance & reliability

  • Able to work constructively with partners